Entry
Name
Diabetic cardiomyopathy - Mus musculus (house mouse)
Description
Diabetic cardiomyopathy has been defined as left ventricular dysfunction that occurs among patients with diabetes mellitus independent of a recognized cause such as coronary artery disease or hypertension. The pathogenesis of diabetic cardiomyopathy broadly involves hyperglycemia, increased circulating fatty acids, and insulin resistance contributing to reactive oxygen species (ROS) generation, mitochondrial dysfunction, impaired calcium metabolism, Renin-Angiotensin System (RAS) activation, and altered substrate metabolism. These effects result in cardiac fibrosis, hypertrophy, cardiomyocyte death, contractile dysfunction, endothelial cell damage and eventually heart failure. In the process of cardiac fibrosis, cardiac fibroblasts are the final effector cell.
Class
Human Diseases; Cardiovascular disease
BRITE hierarchy
Pathway map
Disease
H02498 Diabetic cardiomyopathy
Organism
Mus musculus (house mouse) [GN:
mmu ]
Gene
102634451 Ndufab1-ps; NADH:ubiquinone oxidoreductase subunit AB1b [KO:K03955 ]
104130 Ndufb11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351 ]
110323 Cox6b1; cytochrome c oxidase, subunit 6B1 [KO:K02267 ]
110854 Ptpa; protein phosphatase 2 protein activator [KO:K17605 ]
11545 Parp1; poly (ADP-ribose) polymerase family, member 1 [KO:K24070 ]
11596 Ager; advanced glycosylation end product-specific receptor [KO:K19722 ]
11607 Agtr1a; angiotensin II receptor, type 1a [KO:K04166 ]
11608 Agtr1b; angiotensin II receptor, type 1b [KO:K04166 ]
11739 Slc25a4; solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 [KO:K05863 ]
11740 Slc25a5; solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5 [KO:K05863 ]
11937 Atp2a1; ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 [KO:K05853 ] [EC:7.2.2.10 ]
11938 Atp2a2; ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [KO:K05853 ] [EC:7.2.2.10 ]
11946 Atp5f1a; ATP synthase F1 subunit alpha [KO:K02132 ]
11949 Atp5f1c; ATP synthase F1 subunit gamma [KO:K02136 ]
11950 Atp5pb; ATP synthase peripheral stalk-membrane subunit b [KO:K02127 ]
11951 Atp5mc1; ATP synthase membrane subunit c locus 1 [KO:K02128 ]
11957 Atp5pf; ATP synthase peripheral stalk subunit F6 [KO:K02131 ]
12857 Cox4i1; cytochrome c oxidase subunit 4I1 [KO:K02263 ]
12858 Cox5a; cytochrome c oxidase subunit 5A [KO:K02264 ]
12859 Cox5b; cytochrome c oxidase subunit 5B [KO:K02265 ]
12861 Cox6a1; cytochrome c oxidase subunit 6A1 [KO:K02266 ]
12862 Cox6a2; cytochrome c oxidase subunit 6A2 [KO:K02266 ]
12864 Cox6c; cytochrome c oxidase subunit 6C [KO:K02268 ]
12865 Cox7a1; cytochrome c oxidase subunit 7A1 [KO:K02270 ]
12866 Cox7a2; cytochrome c oxidase subunit 7A2 [KO:K02270 ]
12867 Cox7c; cytochrome c oxidase subunit 7C [KO:K02272 ]
12868 Cox8a; cytochrome c oxidase subunit 8A [KO:K02273 ]
12869 Cox8b; cytochrome c oxidase subunit 8B [KO:K02273 ]
13057 Cyba; cytochrome b-245, alpha polypeptide [KO:K08009 ]
13058 Cybb; cytochrome b-245, beta polypeptide [KO:K21421 ] [EC:1.-.-.-]
17709 COX2; cytochrome c oxidase subunit II [KO:K02261 ]
17710 COX3; cytochrome c oxidase subunit III [KO:K02262 ]
17991 Ndufa2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946 ]
17992 Ndufa4; Ndufa4, mitochondrial complex associated [KO:K03948 ]
17993 Ndufs4; NADH:ubiquinone oxidoreductase core subunit S4 [KO:K03937 ]
18033 Nfkb1; nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 [KO:K02580 ]
18706 Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922 ] [EC:2.7.1.153 ]
18707 Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922 ] [EC:2.7.1.153 ]
18708 Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649 ]
18709 Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649 ]
18710 Pik3r3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649 ]
19013 Ppara; peroxisome proliferator activated receptor alpha [KO:K07294 ]
19697 Rela; v-rel reticuloendotheliosis viral oncogene homolog A (avian) [KO:K04735 ]
20463 Cox7a2l; cytochrome c oxidase subunit 7A2 like [KO:K02270 ]
20525 Slc2a1; solute carrier family 2 (facilitated glucose transporter), member 1 [KO:K07299 ]
20528 Slc2a4; solute carrier family 2 (facilitated glucose transporter), member 4 [KO:K07191 ]
20683 Sp1; trans-acting transcription factor 1 [KO:K04684 ]
21803 Tgfb1; transforming growth factor, beta 1 [KO:K13375 ]
21808 Tgfb2; transforming growth factor, beta 2 [KO:K13376 ]
21809 Tgfb3; transforming growth factor, beta 3 [KO:K13377 ]
22272 Uqcrq; ubiquinol-cytochrome c reductase, complex III subunit VII [KO:K00418 ]
22273 Uqcrc1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414 ]
22333 Vdac1; voltage-dependent anion channel 1 [KO:K05862 ]
22334 Vdac2; voltage-dependent anion channel 2 [KO:K15040 ]
22335 Vdac3; voltage-dependent anion channel 3 [KO:K15041 ]
228033 Atp5mc3; ATP synthase membrane subunit c locus 3 [KO:K02128 ]
230075 Ndufb6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962 ]
28080 Atp5po; ATP synthase peripheral stalk subunit OSCP [KO:K02137 ]
407785 Ndufs6; NADH:ubiquinone oxidoreductase core subunit S6 [KO:K03939 ]
407790 Ndufa4l2; Ndufa4, mitochondrial complex associated like 2 [KO:K03948 ]
54405 Ndufa1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945 ]
55951 Mpc1; mitochondrial pyruvate carrier 1 [KO:K22138 ]
595136 Ndufs5; NADH:ubiquinone oxidoreductase core subunit S5 [KO:K03938 ]
623286 Ndufs6b; NADH:ubiquinone oxidoreductase subunit S6B [KO:K03939 ]
66043 Atp5f1d; ATP synthase F1 subunit delta [KO:K02134 ]
66046 Ndufb5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961 ]
66052 Sdhc; succinate dehydrogenase complex, subunit C, integral membrane protein [KO:K00236 ]
66091 Ndufa3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947 ]
66108 Ndufa9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953 ]
66142 Cox7b; cytochrome c oxidase subunit 7B [KO:K02271 ]
66152 Uqcr10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419 ]
66218 Ndufb9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965 ]
66377 Ndufc1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967 ]
66414 Ndufa12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352 ]
66416 Ndufa7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951 ]
66495 Ndufb3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959 ]
66576 Uqcrh; ubiquinol-cytochrome c reductase hinge protein [KO:K00416 ]
66594 Uqcr11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420 ]
66694 Uqcrfs1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411 ] [EC:7.1.1.8 ]
66916 Ndufb7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963 ]
66925 Sdhd; succinate dehydrogenase complex, subunit D, integral membrane protein [KO:K00237 ]
66945 Sdha; succinate dehydrogenase complex, subunit A, flavoprotein (Fp) [KO:K00234 ] [EC:1.3.5.1 ]
67003 Uqcrc2; ubiquinol cytochrome c reductase core protein 2 [KO:K00415 ]
67126 Atp5f1e; ATP synthase F1 subunit epsilon [KO:K02135 ]
67130 Ndufa6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950 ]
67184 Ndufa13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353 ]
67264 Ndufb8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964 ]
67273 Ndufa10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954 ]
67530 Uqcrb; ubiquinol-cytochrome c reductase binding protein [KO:K00417 ]
67680 Sdhb; succinate dehydrogenase complex, subunit B, iron sulfur (Ip) [KO:K00235 ] [EC:1.3.5.1 ]
67942 Atp5mc2; ATP synthase membrane subunit c locus 2 [KO:K02128 ]
68194 Ndufb4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960 ]
68197 Ndufc2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968 ]
68198 Ndufb2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958 ]
68202 Ndufa5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949 ]
68342 Ndufb10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966 ]
68375 Ndufa8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952 ]
69875 Ndufa11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956 ]
70316 Ndufab1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955 ]
70456 Mpc2; mitochondrial pyruvate carrier 2 [KO:K22139 ]
71679 Atp5pd; ATP synthase peripheral stalk subunit d [KO:K02138 ]
73333 Slc25a31; solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 [KO:K05863 ]
74769 Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922 ] [EC:2.7.1.153 ]
75483 Cox8c; cytochrome c oxidase subunit 8C [KO:K02273 ]
78174 Cox7b2; cytochrome c oxidase subunit 7B2 [KO:K02271 ]
78330 Ndufv3; NADH:ubiquinone oxidoreductase core subunit V3 [KO:K03944 ]
84682 Cox4i2; cytochrome c oxidase subunit 4I2 [KO:K02263 ]
Compound
C00043 UDP-N-acetyl-alpha-D-glucosamine
C00118 D-Glyceraldehyde 3-phosphate
C00236 3-Phospho-D-glyceroyl phosphate
C00352 D-Glucosamine 6-phosphate
C05981 Phosphatidylinositol-3,4,5-trisphosphate
C06156 alpha-D-Glucosamine 1-phosphate
C21011 [Protein]-N(epsilon)-(carboxymethyl)lysine
C21012 [Protein]-N(epsilon)-(carboxyethyl)lysine
Reference
Authors
Riehle C, Bauersachs J
Title
Of mice and men: models and mechanisms of diabetic cardiomyopathy.
Journal
Reference
Authors
Huynh K, Bernardo BC, McMullen JR, Ritchie RH
Title
Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
Journal
Reference
Authors
Lorenzo-Almoros A, Tunon J, Orejas M, Cortes M, Egido J, Lorenzo O
Title
Diagnostic approaches for diabetic cardiomyopathy.
Journal
Reference
Authors
Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L
Title
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.
Journal
Reference
Authors
Zamora M, Villena JA
Title
Contribution of Impaired Insulin Signaling to the Pathogenesis of Diabetic Cardiomyopathy.
Journal
Reference
Authors
Palomer X, Pizarro-Delgado J, Vazquez-Carrera M
Title
Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets?
Journal
Reference
Authors
Mishra PK, Ying W, Nandi SS, Bandyopadhyay GK, Patel KK, Mahata SK
Title
Diabetic Cardiomyopathy: An Immunometabolic Perspective.
Journal
Reference
Authors
Chong CR, Clarke K, Levelt E
Title
Metabolic Remodeling in Diabetic Cardiomyopathy.
Journal
Reference
Authors
Brownlee M
Title
Biochemistry and molecular cell biology of diabetic complications.
Journal
Reference
Authors
Gollmer J, Zirlik A, Bugger H
Title
Established and Emerging Mechanisms of Diabetic Cardiomyopathy.
Journal
Reference
Authors
Boudina S, Abel ED
Title
Diabetic cardiomyopathy revisited.
Journal
Reference
Authors
Varma U, Koutsifeli P, Benson VL, Mellor KM, Delbridge LMD
Title
Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
Journal
Reference
Authors
Mandavia CH, Aroor AR, Demarco VG, Sowers JR
Title
Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.
Journal
Reference
Authors
Falcao-Pires I, Leite-Moreira AF
Title
Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.
Journal
Reference
Authors
Westermeier F, Riquelme JA, Pavez M, Garrido V, Diaz A, Verdejo HE, Castro PF, Garcia L, Lavandero S
Title
New Molecular Insights of Insulin in Diabetic Cardiomyopathy.
Journal
Reference
Authors
Randhawa VK, Dhanvantari S, Connelly K
Title
How Diabetes and Heart Failure Modulate Each Other and Condition Management.
Journal
Reference
Authors
Athithan L, Gulsin GS, McCann GP, Levelt E
Title
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date.
Journal
Reference
Authors
Murarka S, Movahed MR
Title
Diabetic cardiomyopathy.
Journal
Reference
Authors
Thomas CM, Yong QC, Rosa RM, Seqqat R, Gopal S, Casarini DE, Jones WK, Gupta S, Baker KM, Kumar R
Title
Cardiac-specific suppression of NF-kappaB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system.
Journal
Reference
Authors
Brahma MK, Pepin ME, Wende AR
Title
My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy.
Journal
Reference
Authors
Singh VP, Le B, Khode R, Baker KM, Kumar R
Title
Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis.
Journal
Reference
Authors
Singh VP, Baker KM, Kumar R
Title
Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production.
Journal
Reference
Authors
Jia G, DeMarco VG, Sowers JR
Title
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
Journal
Reference
Authors
Kim JA, Wei Y, Sowers JR
Title
Role of mitochondrial dysfunction in insulin resistance.
Journal
Reference
Authors
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA
Title
Association between insulin resistance and the development of cardiovascular disease.
Journal
Reference
Authors
Evangelista I, Nuti R, Picchioni T, Dotta F, Palazzuoli A
Title
Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy.
Journal
Reference
Authors
Joshi M, Kotha SR, Malireddy S, Selvaraju V, Satoskar AR, Palesty A, McFadden DW, Parinandi NL, Maulik N
Title
Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.
Journal
Reference
Authors
Knapp M, Tu X, Wu R
Title
Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.
Journal
Reference
Authors
Asbun J, Villarreal FJ
Title
The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy.
Journal
Reference
Authors
Levick SP, Widiapradja A
Title
The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function.
Journal
Related pathway
mmu00520 Amino sugar and nucleotide sugar metabolism
mmu04933 AGE-RAGE signaling pathway in diabetic complications
KO pathway